What Waklert Is

Active ingredient: Armodafinil.

Available strengths: Commonly 150 mg tablets.

Waklert is a brand name for armodafinil, a wakefulness-promoting agent classified as a CNS stimulant. In the United States, armodafinil is FDA-approved under the brand Nuvigil and as generics; the Waklert brand itself is typically not marketed in the US. It is designed to improve wakefulness but does not replace adequate sleep.

Related conditions: Narcolepsy, obstructive sleep apnea with residual sleepiness, shift work sleep disorder. It has also been prescribed off-label for ADHD, chronic fatigue, and augmentation in major depressive disorder, though such uses require careful medical supervision. For sports contexts, see Legal Status in the USA.

Common Uses

Armodafinil helps reduce excessive daytime sleepiness. It is not a cure for underlying sleep disorders, nor does it replace CPAP therapy for obstructive sleep apnea. Benefits are generally apparent on days it is taken.

  • Shift work sleep disorder - to improve alertness during night or rotating shifts
  • Narcolepsy - to lessen sudden sleep attacks and daytime sleepiness
  • Obstructive sleep apnea - for residual daytime sleepiness despite primary therapy

For cautions and driving advice, see Precautions.

Dosage and Directions

Use exactly as your clinician prescribes. Do not take larger doses or more frequent doses than directed.

  • OSA: Often 150 mg once each morning, used alongside CPAP or other primary therapy.
  • Narcolepsy: 150 mg to 250 mg once each morning.
  • Shift work sleep disorder: 150 mg about 1 hour before the work shift begins.

Swallow tablets with water. Duration of therapy varies based on response and condition; some patients use it chronically with periodic reassessment, while others take it for limited periods. If you have liver impairment, your prescriber may use lower doses. Older adults may also need dose adjustments.

Questions about timing or titration should be discussed with your clinician or pharmacist.

Precautions and Warnings

Armodafinil can affect thinking, vision, and coordination in some individuals. Until you know how it affects you, avoid driving, operating machinery, or engaging in risky activities.

  • Psychiatric history: Use caution with anxiety, mania, psychosis, or depression. Report mood changes, agitation, or suicidal thoughts promptly.
  • Cardiovascular concerns: Can raise blood pressure and heart rate. Patients with structural heart disease, arrhythmias, or uncontrolled hypertension require close monitoring.
  • Severe rash: Rare but serious dermatologic reactions (including Stevens-Johnson syndrome) can occur. Stop immediately and seek care if you develop widespread rash, blistering, mouth sores, or fever.
  • Pregnancy and lactation: Use only if clearly needed after clinician risk-benefit assessment. Discuss contraception needs (see Interactions).
  • Substance use: Although abuse potential is lower than many stimulants, it is a Schedule IV controlled substance in the US. Use only as prescribed.

For medication conflicts, continue to Drug Interactions.

Contraindications

  • Known hypersensitivity to armodafinil, modafinil, or any tablet components
  • History of left ventricular hypertrophy or mitral valve prolapse with stimulant-related adverse reactions

Possible Side Effects

Most people tolerate armodafinil, but side effects may occur. Seek urgent care for severe rash, chest pain, shortness of breath, or hallucinations.

  • Headache
  • Insomnia or restlessness
  • Nausea or decreased appetite
  • Dry mouth
  • Anxiety, irritability, or dizziness

Less common: palpitations, increased blood pressure, blurred vision, mood changes. Rare: serious skin reactions as noted in Precautions.

Drug and Substance Interactions

Armodafinil affects liver enzymes (CYP3A4 induction and CYP2C19 inhibition), which may alter levels of other drugs.

  • Hormonal contraceptives: Reduced effectiveness of pills, patches, rings, implants, and some IUDs during use and for 1 month after stopping. Use reliable non-hormonal backup.
  • Strong CYP3A4 inhibitors: Ketoconazole, itraconazole, clarithromycin may raise armodafinil levels.
  • Strong CYP3A4 inducers: Rifampin, carbamazepine, phenytoin, St. John’s wort may lower armodafinil levels.
  • CYP2C19 substrates: Omeprazole, diazepam, phenytoin, propranolol exposure may increase; monitor and adjust as needed.
  • Warfarin and other anticoagulants: Monitor INR when starting or stopping armodafinil.
  • Other stimulants or caffeine: Additive effects on heart rate, blood pressure, and sleep.

Always inform your clinician about all medicines and supplements you use.

Missed Dose

If you miss a dose, take it when remembered unless it is near your next scheduled dose. Skip the missed dose if it is late in the day to avoid insomnia. Do not double up.

Overdose

Symptoms may include agitation, confusion, anxiety, restlessness, tremor, palpitations, nausea, diarrhea, insomnia, or hallucinations. If overdose is suspected, seek emergency medical help or contact Poison Control at 1-800-222-1222 (USA).

Storage

Store at room temperature 68 to 77 F (20 to 25 C). Keep tablets dry, in the original container, away from heat and light. Keep out of reach of children and pets.

Prices and Availability in USD

Costs vary widely by pharmacy, insurance, discount cards, and whether you use brand or generic. The figures below are rough, cash-pay estimates to illustrate the range in the USA as of recent market patterns.

  • Generic armodafinil 150 mg (30 tablets): about $25 to $120 with common pharmacy discount programs; without discounts, some pharmacies may list $150 to $350.
  • Nuvigil brand 150 mg (30 tablets): often $600 to $900 cash price.
  • Mail-order or 90-day supplies: can lower per-tablet cost for generics.

Note: Prices change frequently. Check multiple pharmacies or use reputable discount tools. Since Waklert is not typically marketed in the US, ask your prescriber for FDA-approved armodafinil products.

Comparable or Alternative Medications

Depending on diagnosis, response, cost, and side effect profile, clinicians may consider these options:

  • Modafinil (Provigil, generics) - similar mechanism; usual doses 100 to 200 mg once daily.
  • Solriamfetol (Sunosi) - dopamine and norepinephrine reuptake inhibitor approved for EDS in OSA and narcolepsy.
  • Pitolisant (Wakix) - histamine H3 receptor inverse agonist; non-stimulant option for narcolepsy.
  • Methylphenidate formulations - stimulants sometimes used off-label for EDS; higher abuse potential, Schedule II.
  • Amphetamine salts or lisdexamfetamine - potent stimulants with Schedule II status; not first-line for OSA-related EDS.
  • Non-drug measures - optimized sleep schedule, light therapy for shift work, adherence to CPAP for OSA, caffeine with sleep hygiene support.

Typical US cash prices per 30 days vary widely: generic modafinil often $20 to $80 with discounts; Sunosi and Wakix are brand-only and can exceed $600 to $1,000 without insurance. Discuss coverage with your insurer and clinician.

Compare dosing guidance with Dosage and Directions and review interaction concerns in Interactions.

Helpful Tips

  • Take armodafinil at the same time each day to stabilize alertness and reduce insomnia risk.
  • Avoid taking late in the day unless prescribed specifically for shift work.
  • Monitor blood pressure and heart rate, especially when starting or changing dose.
  • If using hormonal contraception, add a reliable non-hormonal backup method during therapy and for 1 month after stopping.

Back to top